PURIGEN BIOSYSTEMS, INC.

Profile

Company Names

PURIGEN BIOSYSTEMS, INC.

Addresses

5700 STONERIDGE DR., STE. 100, PLEASANTON, CA 94588

5700 STONERIDGE DRIVE, SUITE 100, PLEASANTON, CA 94588

7026 KOLL CENTER PARKWAY, STE. 225, PLEASANTON, CA 94566

5147 TRINITY PARK DR, ALVISO, CA 95002-0081

Phone Numbers

925-264-1364
650-248-9886

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$61,922,759.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2019-03-22 
$34,444,759.00 
$34,444,759.00 
$0.00 
Equity 
3
2016-03-04 
$26,448,000.00 
$30,828,000.00 
$4,380,000.00 
Equity 
2
2014-07-21 
$200,000.00 
$1,700,000.00 
$1,500,000.00 
Debt 
1
2013-04-10 
$830,000.00 
$3,000,000.00 
$2,170,000.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MIRA 
 
CHAURUSHIYA, PH.D. 
DIRECTOR
PURIGEN BIOSYSTEMS, INC.
BILL 
W. 
COLSTON 
DIRECTOR
QUANTALIFE INC   |  PURIGEN BIOSYSTEMS, INC.
BILL 
W. 
COLSTON, PH.D. 
DIRECTOR
PURIGEN BIOSYSTEMS, INC.
KEVIN 
 
CORCORAN 
DIRECTOR
ECOAST SALES SOLUTIONS, LTD.   |  TEX STAR TESTING + INSPECTION, LLC   |  PURIGEN BIOSYSTEMS, INC.
AMY 
 
HIDDESSEN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PURIGEN BIOSYSTEMS, INC.
MITCHELL 
 
MUTZ 
DIRECTOR
AMPLYX PHARMACEUTICALS, INC.   |  PURIGEN BIOSYSTEMS, INC.   |  PANDION THERAPEUTICS, INC.   |  GOOD THERAPEUTICS, INC.   |  PANDION THERAPEUTICS HOLDCO LLC   |  BONUM THERAPEUTICS, INC.   |  EPIBIOLOGICS, INC.   |  OMNIOX, INC.
STEVE 
 
REICHENBACH 
EXECUTIVE OFFICER
PURIGEN BIOSYSTEMS, INC.   |  PRECISION NANOSYSTEMS INC.
KLINT 
 
ROSE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PURIGEN BIOSYSTEMS, INC.
KLINT 
 
ROSE, PH.D. 
EXECUTIVE OFFICER
PURIGEN BIOSYSTEMS, INC.
JUAN 
 
SANTIAGO 
PROMOTER
PURIGEN BIOSYSTEMS, INC.
JUAN 
G. 
SANTIAGO 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PURIGEN BIOSYSTEMS, INC.
BARNETT 
 
SAUNDERS 
EXECUTIVE OFFICER, DIRECTOR
PURIGEN BIOSYSTEMS, INC.
BARNEY 
E. 
SAUNDERS,PH.D. 
EXECUTIVE OFFICER, DIRECTOR
PURIGEN BIOSYSTEMS, INC.
ANDREW 
 
SCHWAB 
DIRECTOR
TIVAMED INC   |  5AM CO-INVESTORS III, L.P.   |  VIVEVE, INC.   |  FLEXION THERAPEUTICS INC   |  5AM CO-INVESTORS IV, L.P.   |  PURIGEN BIOSYSTEMS, INC.   |  CLEAVE BIOSCIENCES, INC.   |  PEAR THERAPEUTICS, INC.   |  ESCIENT PHARMACEUTICALS INC   |  NIDO BIOSCIENCES, INC.   |  ASSAY DEPOT INC   |  RARECYTE, INC.   |  TMRW LIFE SCIENCES, INC.   |  BEKHEALTH CORP   |  HUMA.AI, INC.   |  ITILITI HEALTH, INC.   |  SKYE BIOSCIENCE, INC.   |  RADIONETICS ONCOLOGY, INC.   |  S2N HEALTH INC.   |  RIDE HEALTH, INC.
JOSEPH 
 
VICTOR 
DIRECTOR, EXECUTIVE OFFICER
PURIGEN BIOSYSTEMS, INC.   |  RARECYTE, INC.
JOSEPH 
J. 
VICTOR 
DIRECTOR
PURIGEN BIOSYSTEMS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-04-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-22 
2018-06-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-04 
2017-10-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-04 
2016-03-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-04 
2014-08-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-07-21 
2013-04-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-04-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#